Section 471(c) and the Road to Repealing 280E
Photo by RDNE Stock project via Pexels.
Section 471(c) of the Internal Revenue Code is a small-business inventory accounting rule. Congress added it in 2017 for hardware stores, bakeries and boutiques, and cannabis never came up. Within a few years, cannabis operators and their tax lawyers were arguing over whether it could ease the 280E tax penalty on their industry.
My thesis is that 471(c) is the best available precedent for how Congress actually moves on 280E. It is also the best warning about where narrow, indirect fixes end up: neutral drafting survives, and it delivers less than advocates hope.
This is a near-term legislative forecast written on October 27, 2026. I'll mark the registers as I go. Established law means statutory text and court holdings. Reasoned extrapolation means a pattern projected forward. Open speculation means a guess I'll label as one. I could not verify current bill numbers, rulemaking status or thresholds for this piece, so I describe those in general terms. Check each against primary sources before you rely on it.
Key takeaways
- Congress usually fixes tax pain through broad small-business provisions, not cannabis-specific bills, and 471(c) is the clearest recent example of that pattern.
- Courts and the IRS have so far limited what 471(c) can do for plant-touching cannabis businesses, so it is a template, not a cure.
- Rescheduling to Schedule III could end 280E without any tax bill, which makes its real status the first fact to check.
What 280E Does and Why It Has Lasted
Section 280E is in the Internal Revenue Code, and its core rule is simple. A business that traffics in Schedule I or II controlled substances cannot take ordinary deductions or credits. Marijuana sits in Schedule I today, so state-licensed plant-touching businesses are caught. Confirm the current wording on uscode.house.gov before quoting it.
The history is a case of Congress writing a narrow fix to one embarrassing fact pattern. It added the provision in the early 1980s after a Tax Court decision let a convicted drug dealer deduct business expenses. The case is commonly identified as Edmondson, but check the name and year before citing it. Nobody at the time was picturing a licensed dispensary with a payroll and a lease.
The mechanism is what turned the whole fight into an accounting dispute. 280E blocks deductions, but it does not touch cost of goods sold, because COGS reduces gross receipts rather than counting as a deduction. So the one offset left is whatever you can legitimately fold into COGS. Every later argument, including the one about 471(c), is a fight over how wide that door opens.
Why has it lasted for over four decades? My analysis, not sourced fact, is that three things protect it. It requires no federal action against any state's licensing regime, so there is no federalism confrontation to provoke. Repealing it costs the Treasury revenue from an industry many members of Congress still prefer not to be seen helping. And the people hurt are mostly small operators without a lobby the size of the industries that win tax relief.
The practical effect is that the effective tax burden on plant-touching operators can far exceed that of ordinary businesses, sometimes turning a modest accounting profit into a large tax bill. I won't put a percentage on it because I can't source one here. Operators will recognize the pattern: strong top-line sales and thin cash after April.
What 471(c) Actually Is, and Why Cannabis Operators Noticed
The 2017 Tax Cuts and Jobs Act added 471(c). In plain terms, it lets businesses under a gross-receipts threshold use simpler inventory methods than the traditional rules require. The threshold is adjusted for inflation every year, so pull the current figure from the latest IRS Revenue Procedure rather than trusting a number from an old article, including this one.
The cannabis hope was straightforward. If a small operator could treat inventory more flexibly, perhaps more of its costs could sit inside COGS, the only place 280E leaves room. Cultivators and manufacturers already have a stronger claim here than retailers. A provision that loosens the rules around what counts as inventory cost sounded like an opening.
The structural point is where the argument turns. Section 471(c) is an accounting-method provision. It governs how and when you account for inventory, and it does not create a new deduction. 280E strips deductions and credits, and it leaves the method question to other parts of the code. A provision that says how you may keep inventory records is not obviously a provision that says what 280E must allow.
That distinction is the whole argument, and it cuts against the cannabis reading. Advocates say a method change can reach costs that would otherwise be deductions. Skeptics answer that you cannot account your way around a statute that bars deductions by name.
For forecasting, the useful part is something else. Congress already wrote relief that reaches cannabis businesses by accident, inside a neutral statute with no cannabis language anywhere in it. That is a documented precedent for the route a future fix might take. It is also a reminder that accidental relief has no one defending its edges.
A caution on my own text: I have described the statute at the level of its general purpose. Exact wording, the current threshold and any interaction with other sections should be confirmed against the Code and IRS guidance before anyone builds a return around them.
Where the Courts and IRS Drew the Line
The standard court reference for how 280E interacts with COGS is the Tax Court's decision involving Patients Mutual Assistance Collective Corp., the Harborside dispensary. Pull the exact citation and any appellate history from ustaxcourt.gov before you cite it. What the case is generally taken to stand for is that a retailer's COGS is limited to the costs of acquiring inventory, and it cannot sweep in broader operating costs just because they relate to selling.
The IRS side needs the same caution. I could not verify whether IRS guidance has addressed 471(c) and 280E head-on, or what it concluded, and I won't characterize it from memory. Look for any published IRS advice or memoranda on the combination, and read the text itself. The summaries that circulate in trade press are often looser than the documents.
The pattern I'd draw is a reasoned extrapolation from how these disputes tend to go. When 280E is in play, courts and the IRS tend to read neutral provisions narrowly. A general-purpose rule, such as a simplified inventory method, does not automatically override a specific prohibition aimed at a class of taxpayers. Specific beats general is an old canon of statutory interpretation, and 280E is about as specific as it gets.
The counter-case deserves a fair hearing. Operators and their advocates argue that the plain text of 471(c) applies to any eligible taxpayer, with no carve-out for trafficking businesses, and that Congress could have excluded them and did not. That is a respectable textual argument. If a court or the IRS ever accepted it, relief would arrive without any new legislation.
Here is how I'd separate the registers. What the rulings held is fact, and you can read it. What they imply for upcoming returns is extrapolation: absent a new appellate decision or explicit IRS guidance, a return that leans on 471(c) to widen COGS is carrying audit risk. I'd treat any position beyond the narrow reading as one that needs a written, advisor-reviewed basis.
Rescheduling: The Shortcut That Could Make Repeal Moot
280E applies only to Schedule I and II substances. A final move of marijuana to Schedule III would therefore remove the trigger without a word of tax legislation. That is the mechanism, and it is why rescheduling is the most direct competitor to every legislative route in this article.
I could not verify the current status of the DEA and DOJ rulemaking. Before you rely on anything here, check federalregister.gov and dea.gov for whether a final rule exists, whether it is in effect, and whether litigation or a stay is pending. Everything below is conditional on those answers.
The case for rescheduling as the likeliest near-term change is procedural. A rule does not need 60 Senate votes, and it sidesteps the committee bottlenecks that stall tax bills. The executive branch can finish a rulemaking on its own schedule, which is a very different timeline from a Congress that routinely misses its own deadlines.
The conservative counter-case is just as concrete. Rules can be challenged in court, delayed, or reversed by a future administration, and a rule that took years to build can be undone with less effort than a statute. That is why some operators still want a statutory fix even if Schedule III arrives. A tax code change is much harder to unwind than an agency's scheduling decision.
Two open questions remain, and I'll flag that the specifics are not established here. First, how a rescheduling rule treats state-licensed operators in practice, since federal law would still treat unlicensed activity differently and the details of the rule matter. Second, whether back-year tax positions are affected, meaning whether 280E would still govern periods before the effective date. My read is that it would, because the penalty attaches to the year in which the trafficking occurred. That is an inference from how tax law usually treats effective dates, so ask your advisor to confirm it against the actual rule text.
What History Says About How Congress Might Repeal 280E

Photo by Guohua Song via Pexels.
The documented precedent is that Congress has moved on cannabis mostly through broad vehicles. The clearest example is the 2018 Farm Bill, which changed the status of hemp inside a large agricultural package. Verify the year and the details before you cite it, but the pattern holds up: hemp passed as part of something bigger, not as a standalone bill.
The 471(c) lesson is similar. Relief for cannabis operators, if it exists at all, came inside a large tax package built for other reasons. For a near-term 280E fix, that is the most realistic route I can reason toward.
As for the bills themselves, check congress.gov for the status of 280E-related legislation in the 119th Congress. Candidates include the Small Business Tax Equity Act and the STATES 2.0 and MORE Act families. I could not confirm that any of them is alive, and standalone cannabis bills have a long record of dying quietly at the end of a session.
My reasoned extrapolation is this. If a fix moves in the next one to three years, the likeliest window is the next large tax package, especially one with an expiring-provision deadline that forces Congress to act. Tax extenders and year-end deals are where small provisions get attached because the whole package is too important to fail. That describes a pattern, not a date, and I would not put a calendar year on it.
The counter-case is strong. Cannabis-specific language has repeatedly failed on floor votes, and members who support the policy often won't vote for anything with the word on it. So riders and neutral drafting may be the only workable path. The speculative version is a provision that fixes the COGS definition for any business in a federally restricted trade, which could carry cannabis without naming it. I flag that as a guess. I haven't seen text that does this.
What Operators Should Plan For in the Next One to Three Years

Photo by Doğan Alpaslan Demir via Pexels.
Plan around three scenarios, and treat the probabilities as your own judgment, because I won't hand you numbers I can't source.
- Rescheduling takes effect and 280E stops applying. Confirm with a tax professional how to document the transition year, since the effective date will determine which period gets which treatment.
- Rescheduling stalls and 280E stays. Keep COGS documentation tight, because that is the only defensible offset. Inventory costing, production records and cost allocations should all be able to survive an audit.
- A broad tax vehicle carries a targeted fix. This is the least certain scenario, and it is the one the 471(c) pattern points to. Expect it to be narrower than the industry wants.
The risk factors are litigation, administrative turnover, and the possibility that relief arrives without retroactive effect. Any one of them can turn a good headline into an unchanged tax bill. An operator who books a refund before the rule is final, or assumes a stay won't land, is making a bet and not a plan.
Some advice holds in every outcome. Keep clean books, with inventory and cost records you could hand an examiner tomorrow. Work with a tax advisor who has handled 280E examinations and not just general small-business returns. And don't take any tax position that depends on a forecast, including mine. If a position only works when Congress or the DEA acts on a particular schedule, it is not ready to file.
The sharpest lesson from 471(c) is that Congress rewards neutrality. The provisions that survive are the ones that never say cannabis, which is also why they tend to under-deliver for it. A rule written for hardware stores can be read narrowly the moment a cannabis operator invokes it, and no one in Congress has a stake in defending the broader reading.
My stance is that the safest near-term bet is administrative change through rescheduling, with legislation as the backstop. That is a judgment about process, since agencies can finish what Congress cannot start, and it could still be undone by courts or a new administration. Before making any tax decision, check the status of both the rulemaking on federalregister.gov and the bills on congress.gov, and then have a cannabis tax advisor read the actual text.
Sources
- Cannabis Rescheduling and the Future of 280E
- Section 280E Cannabis Tax Deductions After Schedule III
- DOJ Immediately Reschedules State-Licensed Medical Cannabis to Schedule III — and Restarts the Clock on Broader Rescheduling
- Cannabis and Section 280E: What Rescheduling Actually Changed
- Cannabis & §280E: Rescheduling Changed Everything on April 22, 2026
- What is 280E? 2026 Cannabis Tax Rules Explained



